Skip to main content

Tolerance to Pituitary-Adrenal Axis Activation by Anticancer Drugs in Normal and Tumour-Bearing Rats

  • Conference paper
Disease, Metabolism and Reproduction in the Toxic Response to Drugs and Other Chemicals

Part of the book series: Archives of Toxicology ((TOXICOLOGY,volume 7))

Abstract

Cisplatinum given intravenously (i.V.), hydroxyurea given orally (os), procarbazine (os) and L-asparaginase (i.V.), on a decreasing scale, produce significant (p< 0.01) adrenocortical activation over 4-h period at a single dose per kg 10 times higher than those employed in human therapy. Only hydroxyurea retained this activity after a 5-day treatment both in normal and Walker carcinosarcoma-bearing rats. Adrenocortical activation depends on the presence of pituitary ACTH both after single or repeated treatments.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Calabresi P, Parks RE Jr (1980) Chemotherapy of neoplastic disease. In: Gilman AG, Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics, 6th edn. Saunders, New York, pl 301

    Google Scholar 

  • Craddock CG (1978) Corticosteroid-induced lymphopenia, immunosuppression and body defense. Ann Intern Med 28: 564–566

    Google Scholar 

  • Preziosi P, Marmo E (1960) Effets de la dexaméthasone et de l’association dexaméthasone-tétracycline sur certaines tumeurs expérimentales. Chemotherapia 2: 89–112

    Article  Google Scholar 

  • Preziosi P, Vacca M (1982) Etomidate and corticotrophic axis. Arch Int Pharmacodyn Ther 256: 308–310

    PubMed  CAS  Google Scholar 

  • Salmon SE (1980) Cancer chemotherapy. In: Meyers FH, Jawetz E, Goldfien A (eds) Medical pharmacology. Lange Med Publ, Los Altos, California, pp 477–513

    Google Scholar 

  • Vacca M, Cerrito F, Balzamo S, Preziosi P (1982) Pituitary adrenal axis and plasma prolactin following administration of clinically-useful anticancer drugs. Presented at the XXI Ital Cong of Pharmacology, June 2–5, 1982, Naples, Italy. Abs Book, p 191 (abstr. 51)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer-Verlag

About this paper

Cite this paper

Vacca, M., Preziosi, P. (1984). Tolerance to Pituitary-Adrenal Axis Activation by Anticancer Drugs in Normal and Tumour-Bearing Rats. In: Chambers, P.L., Preziosi, P., Chambers, C.M. (eds) Disease, Metabolism and Reproduction in the Toxic Response to Drugs and Other Chemicals. Archives of Toxicology, vol 7. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69132-4_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-69132-4_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-12452-8

  • Online ISBN: 978-3-642-69132-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics